{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:40:37Z","timestamp":1790487637377,"version":"4.1.0"},"reference-count":45,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/501100010457","name":"CHU de Bordeaux","doi-asserted-by":"crossref","award":["AOI (Appel d\u2018offre interne) CHU de Bordeaux"],"award-info":[{"award-number":["AOI (Appel d\u2018offre interne) CHU de Bordeaux"]}],"id":[{"id":"10.13039\/501100010457","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondation Bordeaux Universit\u00e9 (Assistance Ventilatoire \u00e0 Domicile (AVAD) and F\u00e9d\u00e9ration Girondine de Lutte contre les Maladies Respiratoires","award":["Fonds sur les maladies chroniques"],"award-info":[{"award-number":["Fonds sur les maladies chroniques"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,5,28]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density<jats:italic>in situ<\/jats:italic>in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival<jats:italic>in vitro<\/jats:italic>(\u201cFibrochir\u201d study).<\/jats:p><jats:p>A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45<jats:sup>+<\/jats:sup>FSP1<jats:sup>+<\/jats:sup>cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.<\/jats:p><jats:p>We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.<\/jats:p><jats:p>Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.<\/jats:p>","DOI":"10.1183\/13993003.02173-2018","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T12:24:07Z","timestamp":1560428647000},"page":"1802173","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Fibrocyte accumulation in the airway walls of COPD patients"],"prefix":"10.1183","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-9625","authenticated-orcid":false,"given":"Isabelle","family":"Dupin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-8433","authenticated-orcid":false,"given":"Matthieu","family":"Thumerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Maurat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5858-8327","authenticated-orcid":false,"given":"Florence","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edm\u00e9e","family":"Eyraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Begueret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Trian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Montaudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Marthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Girodet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-0343","authenticated-orcid":false,"given":"Patrick","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"2024102101003485000_54.3.1802173.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158"},{"key":"2024102101003485000_54.3.1802173.2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019. https:\/\/goldcopd.org\/wp-content\/uploads\/2018\/11\/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf Date last accessed: January 1, 2019."},{"key":"2024102101003485000_54.3.1802173.3","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/resp.12780","article-title":"Acute exacerbation of COPD","volume":"21","author":"Ko","year":"2016","journal-title":"Respirology"},{"key":"2024102101003485000_54.3.1802173.4","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.040527"},{"key":"2024102101003485000_54.3.1802173.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2024102101003485000_54.3.1802173.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0873-2159(15)30121-5"},{"key":"2024102101003485000_54.3.1802173.7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"2024102101003485000_54.3.1802173.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516385"},{"key":"2024102101003485000_54.3.1802173.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2024102101003485000_54.3.1802173.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197410102911503"},{"key":"2024102101003485000_54.3.1802173.11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol Med"},{"key":"2024102101003485000_54.3.1802173.12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2015.08.043","article-title":"Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway","volume":"137","author":"Dupin","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024102101003485000_54.3.1802173.13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/all.13061","article-title":"Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease","volume":"72","author":"Wright","year":"2017","journal-title":"Allergy"},{"key":"2024102101003485000_54.3.1802173.14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.380"},{"key":"2024102101003485000_54.3.1802173.15","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1038\/ncomms9792","article-title":"Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Nat Commun"},{"key":"2024102101003485000_54.3.1802173.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.08.027"},{"key":"2024102101003485000_54.3.1802173.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1117988108"},{"key":"2024102101003485000_54.3.1802173.18","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0455OC"},{"key":"2024102101003485000_54.3.1802173.19","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207696"},{"key":"2024102101003485000_54.3.1802173.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1423OC"},{"key":"2024102101003485000_54.3.1802173.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201410-1874OC"},{"key":"2024102101003485000_54.3.1802173.22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2422060029"},{"key":"2024102101003485000_54.3.1802173.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201409-1582OC"},{"key":"2024102101003485000_54.3.1802173.24","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199001000-00010"},{"key":"2024102101003485000_54.3.1802173.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00124605"},{"key":"2024102101003485000_54.3.1802173.26","doi-asserted-by":"publisher","DOI":"10.1038\/nri2990"},{"key":"2024102101003485000_54.3.1802173.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200311-1535OC"},{"key":"2024102101003485000_54.3.1802173.28","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.130.2.393"},{"key":"2024102101003485000_54.3.1802173.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00358.x"},{"key":"2024102101003485000_54.3.1802173.30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420997"},{"key":"2024102101003485000_54.3.1802173.31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-2963-4_3","article-title":"Flow cytometric identification of fibrocytes in the human circulation","volume":"1343","author":"Hu","year":"2015","journal-title":"Methods Mol Biol"},{"key":"2024102101003485000_54.3.1802173.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007475"},{"key":"2024102101003485000_54.3.1802173.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2011.01344.x"},{"key":"2024102101003485000_54.3.1802173.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196806202782501"},{"key":"2024102101003485000_54.3.1802173.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200601-037OC"},{"key":"2024102101003485000_54.3.1802173.36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1766"},{"key":"2024102101003485000_54.3.1802173.37","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00025.2015"},{"key":"2024102101003485000_54.3.1802173.38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1165\/rcmb.2017-0301PS","article-title":"Fibrocytes in asthma and chronic obstructive pulmonary disease: variations on the same theme","volume":"58","author":"Dupin","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102101003485000_54.3.1802173.39","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-50"},{"key":"2024102101003485000_54.3.1802173.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.048"},{"key":"2024102101003485000_54.3.1802173.41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Heukels","year":"2018","journal-title":"Respir Res"},{"key":"2024102101003485000_54.3.1802173.42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.chest.2016.10.031","article-title":"Improving the management of COPD in women","volume":"151","author":"Jenkins","year":"2017","journal-title":"Chest"},{"key":"2024102101003485000_54.3.1802173.43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0487OC"},{"key":"2024102101003485000_54.3.1802173.44","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7"},{"key":"2024102101003485000_54.3.1802173.45","first-page":"3386","article-title":"The gatekeeper effect of epithelial\u2013mesenchymal transition regulates the frequency of breast cancer metastasis","volume":"63","author":"Xue","year":"2003","journal-title":"Cancer Res"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02173-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:39:04Z","timestamp":1740382744000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02173-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,5]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1183\/13993003.02173-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02173-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]}}}